B. Riley Financial Declares Preferred Stock Dividends
LOS ANGELES, April 9, 2024 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company") has declared cash...
Month: April 2024
B. Riley Financial Declares Preferred Stock Dividends
LOS ANGELES, April 9, 2024 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company") has declared cash...
Jodi Nishimura, One of the East Bay’s Top Agents, Brings Her Well-Known Boutique Brand to Real
Addition of Kai Real Estate adds to Real’s growing presence in California Contacts Investor inquiries: Ravi Jani Vice President, Investor...
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
BEDFORD, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s...
Acrivon Therapeutics Enters $130 Million PIPE Financing
DENVER, Colo., Apr 09, 2024 (247marketnews.com)- Acrivon Therapeutics, Inc. (NASDAQ:ACRV) reported entering into a securities purchase agreement to raise approximately...
Laser Photonics Secures Order From L3Harris Technologies for LaserTower Marking & Engraving System
Contacts Investor Relations Contact: laser@haydenir.com Contact: Karla Kizzort Laser Photonics Corporation kkizzort@laserphotonics.com Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading...
Dragonfly Energy to Report Fourth Quarter and Year End 2023 Financial and Operational Results on April 15, 2024
RENO, Nev., April 09, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker...
Dragonfly Energy to Report Fourth Quarter and Year End 2023 Financial and Operational Results on April 15, 2024
RENO, Nev., April 09, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker...
Calliditas Therapeutics to Attend Conferences in April
STOCKHOLM, April 9, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused...
MariMed Closes Acquisition of Second Maryland Dispensary
NORWOOD, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state...
Rail Vision Wins US Order Advancing Railway Safety with AI Technology
The customer is a large Class 1 freight rail company in the US Ra’anana, Israel, April 09, 2024 (GLOBE NEWSWIRE)...
CPI Card Group® Announces Expansion with New Production Facility in Fort Wayne, Indiana
New facility to support long-term growth by doubling footprint in Fort Wayne. Contacts Media Contact: Andy Sedlak Dix & Eaton...
Identiv Highlights Excellence in Specialty IoT Solutions at RFID Journal LIVE! 2024
IoT leader invites customers, partners, and investors to connect at booth 409 at the world’s largest RFID industry show Contacts...
Genflow Biosciences PLC Announces Notification of Major Holdings – 1
LONDON, UK / ACCESSWIRE / April 9, 2024 / Genflow Biosciences PLC (LSE:GENF)(OTCQB:GENFF) TR-1: Standard form for notification of major...
Gilat Received Multimillion-Dollar Order from a Leading Defense Organization
PETAH TIKVA, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in...
EVgo Expands Autocharge+ to More Than 50 Electric Vehicle Models
EVgo’s Autocharge+ offers drivers the ability to seamlessly initiate fast charging sessions by simply plugging in – no app, RFID...
Cyngn Deploys with Polaris, Global Powersports Leader
MENLO PARK, Calif., April 9, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN), today announced its initial deployment...
Cognyte Reports Fourth Quarter and Fiscal Year Ended January 31, 2024 Financial Results
Delivers Revenue Growth and Strong Margin Expansion in Both Fourth Quarter and Full Year Guides to Fiscal 2025 Revenue of...
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
Late-Breaking Abstract Presentation to Showcase Results from SHORE Registry Highlighting Benefits of Surveillance with HeartCare Contacts CareDx, Inc. Media Relations...
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and...
ARKO Corp. Subsidiary GPM Investments Kicks Off Months of Pizza Celebration with its $4.99 Pizza Program
RICHMOND, Va., April 09, 2024 (GLOBE NEWSWIRE) -- GPM Investments, LLC (“GPM”), a wholly owned subsidiary of ARKO Corp. (Nasdaq:...
Altair Wins 2024 Google Cloud North America Partner of the Year Award for Diversity, Equity, and Inclusion
Award recognizes Google Cloud partner that best prioritized DEI initiatives to transform and strengthen their organization TROY, Mich., April 9,...
Acrivon Therapeutics Announces $130 Million Private Placement Financing
WATERTOWN, Mass, April 09, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage...
BrainStorm Cell Therapeutics Receives Approval from FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
DENVER, Colo., Apr 09, 2024 (247marketnews.com)- BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) stated that the U.S. Food and Drug Administration (FDA)...
ZoomInfo and TrustRadius Partner To End Revenue Anxiety
This long-awaited partnership allows sales teams to match accounts researching their product(s) on TrustRadius with decision maker contact information in...
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting
SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in...
Upbound Group, Inc. Announces Timing of First Quarter 2024 Financial Results
Contacts Investor Contact: Jeff Chesnut SVP Strategy & Corporate Development 972-801-1108 jeff.chesnut@upbound.com Upbound Group, Inc. (the "Company" or "Upbound") (NASDAQ:...
Treace to Report First Quarter 2024 Financial Results
PONTE VEDRA, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a...
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year QuarterBeverage-Alcohol Net Revenue Increases 165%...
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Contacts Syros Karen Hunady Director of Corporate Communications & Investor Relations 1-857-327-7321 khunady@syros.com Investor Hannah Deresiewicz Stern Investor Relations, Inc....
SNDL to Participate in Upcoming International Cannabis Conferences
CALGARY, AB, April 9, 2024 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") is pleased to announce that Zach...
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
The addition of both Dr. Brenner and Dr. Blouw substantially expands Plus internal expertise in key areasDr. Brenner will maintain...
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
CAMBRIDGE, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the...
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Goal is to develop an oral STAT6 degrader investigational new drug with potential to address the needs of patients with...
Neogen Announces Third-Quarter 2024 Results
LANSING, Mich., April 9, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today the results of the third quarter ended...
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
Contacts Investor Contact Kendra Sweeney kendra.sweeney@neogenomics.com Media Contact Andrea Sampson asampson@sampsonprgroup.com NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services...
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Clinical data readout expected end of Q3 2024 SER-155 and other Seres microbiome therapeutic candidates have potential to expand microbiome...
Iridium Signs Five-Year Contract with L3Harris to Protect FAA Critical Infrastructure
Latest deployment of Iridium STL will provide a resilient timing sync service to data center facilities across the U.S. MCLEAN,...
POSaBIT to Host Fourth Quarter and FY 2023 Earnings Conference Call
Contacts Media Relations: Oscar Dahl 855-767-2248 hello@posabit.com Management: Ryan Hamlin Co-founder and CEO of POSaBIT 855-767-2248 investors@posabit.com POSaBIT Systems Corporation...
Gogo Secures FCC Regulatory Approval for Gogo Galileo Terminals
Remains on Track for Expected Commercial Launch Later This Year BROOMFIELD, Colo., April 9, 2024 /PRNewswire/ -- Gogo Business Aviation...